ALK Abell Earnings Estimate
ALK Abell Earnings per Share Projection vs Actual
About ALK Abell Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of ALK Abell earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current ALK Abell estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as ALK Abell fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.ALK-Abell AS, a pharmaceutical company, develops and markets products and services for allergy and allergic asthma in Europe, North America, and internationally. ALK-Abell AS was founded in 1923 and is headquartered in Hrsholm, Denmark. ALK Abell operates under Biotechnology classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 2379 people.
Pair Trading with ALK Abell
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ALK Abell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will appreciate offsetting losses from the drop in the long position's value.Moving against ALK Stock
| 0.47 | JYSK | Jyske Bank AS Earnings Call This Week | PairCorr |
| 0.32 | DANSKE | Danske Bank AS | PairCorr |
| 0.31 | PNDORA | Pandora AS | PairCorr |
The ability to find closely correlated positions to ALK Abell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ALK Abell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ALK Abell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ALK Abell AS to buy it.
The correlation of ALK Abell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ALK Abell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ALK Abell AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ALK Abell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in ALK Stock
ALK Abell financial ratios help investors to determine whether ALK Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALK with respect to the benefits of owning ALK Abell security.